{"data":{"type":"company_profile","id":161004,"entity_id":"wefunder:company:161004","attributes":{"canonical_url":"https://wefunder.com/imago","generated_at":"2026-06-24T07:25:07Z","updated_at":"2026-06-24T05:01:30Z","entity_ids":{"company":"wefunder:company:161004","slug":"wefunder:company_slug:imago"},"profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":false,"privacy_mode":"unlisted","invite_only":false},"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-24T07:25:07Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-24T05:01:30Z","as_of":"2026-06-24T07:25:07Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-24T05:01:30Z","as_of":"2026-06-24T07:25:07Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-03-21T17:10:02Z","as_of":"2026-06-24T07:25:07Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-03-21T17:10:02Z","as_of":"2026-06-24T07:25:07Z","confidence":"medium"}}},"company":{"id":161004,"entity_id":"wefunder:company:161004","slug":"imago","name":"Imago Rehab","tagline":"AI \u0026 robotics for the $210B rehab industry","story":"Imago Rehab is transforming recovery for the 100M+ Americans living with neurological and cardiovascular conditions. Leveraging AI and wearable robotics, Imago Rehab’s clinician-led telerehab platform provides patients with comprehensive in-home therapy, for the first time ever.\u0026nbsp;Led by entrepreneurs, clinicians, and engineers from Harvard University, MIT, Humana, CVS/Aetna, Anthem, and Intel, and backed by investors AARP, Safar Partners, and Cybernetix, Imago Rehab is revolutionizing the $210B neurological and cardiovascular rehab market.With outcomes 5X better than in-clinic therapy, Imago Rehab is delivering the unprecedented recovery results that patients deserve.In just two years, Imago Rehab has hit three critical milestones: superior clinical outcomes, broad insurance coverage, and exceptional cost efficiency.For those who survive cardiovascular and neurologic events, such as peripheral artery disease, heart failure, and stroke, life often changes instantly. Once simple tasks like getting dressed, cooking a meal, or walking down the sidewalk with a loved one can become near impossible.\u0026nbsp;Patients who are recovering from these events are prescribed various forms of rehabilitation therapy, but access is complex. With only a few high-quality rehabilitation centers available, patients nationwide struggle to access care.Even when accessing care isn’t an issue, in-clinic therapy programs fall short. The logistical barriers, lack of continuity between clinic and day-to-day activities, and limited service availability leads to high attrition rates of over 30%, poor outcomes, and, in many cases, permanent disability. These challenges place a significant emotional and financial toll on survivors and their families, adding to a cycle of hopelessness.There is a critical need for a therapy solution that works.Imago Rehab makes rehab convenient and effective.The Imago Platform integrates a telerehab clinic, wearable robotic devices, and advanced AI analysis to deliver highly personalized rehabilitation programs that work.\u0026nbsp;Imago Rehab uses AI to make real-time adjustments to therapy programs, provides asynchronous education to sustain progress between visits, and securely reports patient progress through Electronic Health Records (EHR) to coordinate care across clinicians and ensure a holistic approach to each patient’s recovery.At the heart of our platform is our patent-protected Imago Glove. This innovative device is currently used to accelerate stroke recovery through personalized and gamified therapy programs and exercises.This system delivers high-repetition, high-intensity exercises, which can be completed from the comfort of home. These exercises are essential for neuroplasticity and recovery and lead to superior recovery outcomes.\u0026nbsp;These patents are under Harvard University's name and are exclusively licensed to Imago.Our unique integration of wearable, robotic technology and customized rehab programs ensures that effective therapy extends into the home environment, bridging the critical gap left by traditional therapy solutions.We make home recovery possible by seamlessly integrating rehabilitation into daily activities from the comfort of home. By eradicating the need for in-person rehab visits, the path to recovery is convenient, accessible, and personalized to each patient’s needs.Imago users report substantial improvements in physical function and independence, delivering outcomes that are 5x better than traditional therapies, impressing patients and clinicians.Our breakthrough solutions are transforming lives, with patients and clinicians recognizing the exceptional, unprecedented results.\u0026nbsp;Imago Rehab’s team is a dynamic powerhouse of experts from Harvard, MIT, Humana, CVS/Aetna, Anthem, Intel, and leading innovators in healthcare and engineering.\u0026nbsp;With 10 decades of combined experience, including working for insurers impacting 42M healthcare subscribers, managing a $7B+ clinical spend portfolio, and bringing a company to IPO, our team excels at bridging the gap between cutting-edge technology and patient-centered healthcare solutions.\u0026nbsp;The need for effective and accessible solutions has never been greater and Imago Rehab is at the forefront of innovation for neurological and cardiovascular recovery - a $210B market.Imago is set to revolutionize the market by integrating robotic technology with clinician-led care. Our telerehab platform addresses immediate rehabilitation needs and opens doors to orthopedic, pulmonary, and geriatric rehab care. We envision a future where all rehabilitation needs are met effortlessly in a market owned by Imago Rehab.\u0026nbsp;\u0026nbsp;Our business model seamlessly integrates advanced technology with personalized, clinician-led care, ensuring high profitability and significant growth opportunities.\u0026nbsp;By leveraging existing claims codes with our insurer partnerships, we accelerate our market entry and reduce approval risk, paving the way for rapid commercialization. This is backed by an impressive Lifetime Value (LTV) to Customer Acquisition Cost (CAC) ratio of 40X.Our revenue is generated from two primary sources:\u0026nbsp; 1) insurance-covered therapy services\u0026nbsp; 2) wearable devices, including the Imago GloveOur robust partnerships with 23 insurers, including Medicare, Harvard Pilgrim HealthCare, United Healthcare, Humana, Anthem and other BlueCross BlueShield plans, guarantee broad access and affordability, with the potential to reach 311M patients. On average, each patient is granted 50 visits per year with over $5K in reimbursements.*Projections not guaranteed Imago Rehab is strategically positioned to exceed $56.5M in therapy and device sales by 2028.For these projections, we assume the patient referral partnership we have secured will generate a minimum of 100 new patient referrals each month in 2025. We expect to need $4.5M to reach profitability. We’re currently raising $2.5M this round. We’ll raise $2M in a future round to reach profitability ahead of a Series A in the $7-9M range. We believe this will allow faster growth, greater revenue opportunities, and position us well for these projections.By developing additional robotic wearables with the Harvard Lab, forming more insurer partnerships, and extending our services to adapt to market needs across the United States, we’re set for rapid expansion and mainstream adoption.We’re focused on achieving these 4 key strategic milestones:Expand Service Across 50 States: Increase our service reach across the U.S. by the end of 2027.\u0026nbsp;Grow Patient Numbers and ARR: Boost our Patient Base and Annual Recurring Revenue by 394% within the next year.Advance Tech Platform \u0026amp; Release a Patient App: Enhance our technology platform and launch a dedicated patient app by the end of 2024.Develop Version 2.0 of the Imago Glove: Create the next generation of our wearable technology, scheduled for release in early 2027.Digital health companies have been on a tear as more demonstrate the business case and profitability of their models. This successful approach has never been applied to cardiovascular and neurological rehabilitation—until now. Imago Rehab’s integration of advanced robotics and AI with deep clinical expertise positions us to achieve incredible business outcomes for our investors.The demand for advanced rehabilitation solutions has never been higher. Investing in Imago Rehab means more than supporting groundbreaking AI and robotic technology, it means investing in a future where millions can regain their independence and quality of life.\u0026nbsp;Our community round democratizes healthcare innovation, allowing you to invest on the same terms as top investors like AARP, Safar Partners, and Cybernetix. Together we can transform rehabilitation as we know it, ensuring better outcomes for millions of patients.","location":"Lowell, MA","website":"https://imagorehab.com/","total_amount_raised":127625,"total_investors":147,"is_funded":true,"is_active":true,"quality_score":5,"related_urls":["https://wefunder.com/imago","https://imagorehab.com/"]},"media":{"share_image_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/161004/xxl_blob.jpg","logo_url":"https://uploads.wefunder.com/uploads/company/logo/161004/large_blob.png","header_media_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/161004/standard_blob.jpg","cover_photo_url":"https://uploads.wefunder.com/uploads/company/header_media_photo/161004/standard_blob.jpg"},"links":{"company_url":"https://imagorehab.com/","linkedin_url":"https://linkedin.com/company/imago-rehab"},"highlights":[{"id":62781,"name":"venture_backed","url":"venturebacked","presentable_name":"VC-Backed","description":"Raised $250K or more from a venture firm","image_url":"https://uploads.wefunder.com/2021/profile-highlights-check.svg"},{"id":75539,"name":"fast_growth","url":"fastgrowth","presentable_name":"Fast Growth","description":"Revenue growing 2X/yr for at least prior 6 months","image_url":"https://uploads.wefunder.com/2021/profile-highlights-bar-graph.svg"},{"id":75537,"name":"repeat_founder","url":"repeatfounder","presentable_name":"Repeat Founder","description":"Started a prior company with $2M+ in funding or revenue","image_url":"https://uploads.wefunder.com/2021/profile-highlights-replay.svg"}],"quick_facts":[{"index":1,"claim_id":"claim-fact-1","value":"Backed by AARP’s AgeTech Collaborative \u0026amp; leading VCs Safar Partners \u0026amp; Cybernetix Ventures"},{"index":2,"claim_id":"claim-fact-2","value":"5X better recovery results than traditional, in-clinic rehab"},{"index":3,"claim_id":"claim-fact-3","value":"Insurance coverage via 23 top insurers including Medicare, United Healthcare, Humana \u0026amp; Anthem"},{"index":4,"claim_id":"claim-fact-4","value":"3 patents awarded for the Imago Glove, with 1 additional patent pending"},{"index":5,"claim_id":"claim-fact-5","value":"World-class team from Harvard University, MIT, Humana, CVS/Aetna, Anthem \u0026amp; Intel"},{"index":6,"claim_id":"claim-fact-6","value":"CO-Principal Investigator with Harvard University and Mass General Hospital on a $5M NSF grant."},{"index":7,"claim_id":"claim-fact-7","value":"Forecasting $46.8M in revenue by 2028 (not guaranteed)"},{"index":8,"claim_id":"claim-fact-8","value":"Massive $210B neurological and cardiovascular rehab market"}],"team":[{"id":5080710,"entity_id":"wefunder:company_role:5080710","user_entity_id":"wefunder:user:4405803","role":"employee","name":"Chris Dugan","title":"CEO","bio":"Executive roles at CVS/Aetna, Humana, and Hinge Health. Managed product portfolio impacting $7B clinical spend. Expertise in Health Insurance, Value-based Care, Virtual and Digital Clinical Care Innovations. University of Maryland BA and MBA.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5080710/square_blob.jpg?1725979827","profile_url":"https://wefunder.com/chris.dugan.2","personal_url":"https://imagorehab.com/","linkedin_url":"https://linkedin.com/in/jcdugan99/","related_urls":["https://wefunder.com/chris.dugan.2","https://imagorehab.com/"]},{"id":5080750,"entity_id":"wefunder:company_role:5080750","user_entity_id":"wefunder:user:4405877","role":"employee","name":"Gene Tacy","title":"COO \u0026 President","bio":"Engineering and manufacturing veteran. Led Myomo Inc. to IPO, scaling the company from 4 to 100+ employees. Developed proof-of-concept products for 5 startups. Clarkson University Electrical \u0026amp; Computer Engineering BS and Electrical Engineering MS.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5080750/square_blob.jpg?1724086733","profile_url":"https://wefunder.com/gene.tacy","linkedin_url":"https://linkedin.com/in/gene-tacy-96a9164/","related_urls":["https://wefunder.com/gene.tacy"]},{"id":5080749,"entity_id":"wefunder:company_role:5080749","user_entity_id":"wefunder:user:4405822","role":"founder","name":"Kristin Nuckols","title":"Co-Founder \u0026 Chief Clinical Officer","bio":"Award-winning occupational therapist. Led stroke teams in top rehab hospitals. Former Harvard researcher. Developed Imago’s clinical protocol with 5X+ motor gains. James Madison University MOT. Boston University OTD.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5080749/square_blob.jpg?1724086733","profile_url":"https://wefunder.com/kristin.nuckols","linkedin_url":"https://linkedin.com/in/kristin-nuckols/","related_urls":["https://wefunder.com/kristin.nuckols"]},{"id":5168494,"entity_id":"wefunder:company_role:5168494","user_entity_id":"wefunder:user:4526842","role":"founder","name":"Conor Walsh","title":"PhD, Co-Founder \u0026 Board Member","bio":"Wearable robotics visionary. Harvard bioengineering professor and Harvard Biodesign Lab founder. Biomechanics pioneer with 20+ patents. Trinity College Mechanical \u0026amp; Manufacturing Engineering BS. MIT Mechanical Engineering MS and PhD.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5168494/square_blob.jpg?1730231255","profile_url":"https://wefunder.com/conor.walsh.1","related_urls":["https://wefunder.com/conor.walsh.1"]},{"id":5249976,"entity_id":"wefunder:company_role:5249976","user_entity_id":"wefunder:user:4494787","role":"employee","name":"Chris Burns","title":"Chief Marketing Officer","bio":"Growth Whisperer \u0026amp; Past Founder. Past C-Suite marketing, strategy, and growth roles at companies from startups to Fortune 500. Deep industry expertise spanning Healthcare to Hospitality. Chicago Booth MBA.","avatar_url":"https://uploads.wefunder.com/uploads/company_role/custom_photo/5249976/square_blob.jpg?1727399063","profile_url":"https://wefunder.com/chris.burns.1","related_urls":["https://wefunder.com/chris.burns.1"]}],"featured_investors":[{"id":9294,"entity_id":"wefunder:company_investor_profile:9294","investor_profile_id":3634869,"investor_profile_entity_id":"wefunder:investor_profile:3634869","subject_entity_id":"wefunder:notable_investor:3937","name":"Safar Partners","role_title":"Managing Partner","bio":"Safar Partners nurtures innovations in sustainable energy, clean water, food management, and healthcare to tackle today’s biggest challenges, including climate change and global health.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTMzMDc2LCJwdXIiOiJibG9iX2lkIn19--21ad4fddf358a305bfaf52a21408a0c30bb85171/filename%20(12)","profile_url":"https://wefunder.com/safar.partners","endorsement_quote":"An investment in Imago Rehab is an exciting and unique opportunity for the public to directly invest in a digital health platform that has already shown significant improvement in the care and outcomes of stroke survivors. This investment is an opportunity to drastically improve the lives of over 5 million stroke survivors with lasting motor impairment and revolutionize the $38 billion stroke rehabilitation market through Imago’s superior telehealth virtual clinic therapies and devices.","endorsement_name":"Arunas Chesonis","investment_total":2630589,"investment_info":"Invested $1,000,000 this round \u0026 $1,630,589 previously","is_lead_investor":false,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/safar.partners"]},{"id":9830,"entity_id":"wefunder:company_investor_profile:9830","investor_profile_id":3971000,"investor_profile_entity_id":"wefunder:investor_profile:3971000","subject_entity_id":"wefunder:user:4479866","name":"Ryan Wheeler","role_title":"","bio":"Ryan Wheeler has 30+ years of healthcare industry expertise as a founder, investor, and executive.","avatar_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTk3MDY1LCJwdXIiOiJibG9iX2lkIn19--a8fcd09514cf6ca34378c68115c0b666c081a46b/filename","profile_url":"https://wefunder.com/ryan.wheeler.1","endorsement_quote":"I am delighted to serve as the lead investor in a tele-rehabilitation startup, Imago Rehab. Chris and the Imago Rehab team have demonstrated exceptional clinical efficacy by providing virtual neurological and cardiovascular rehabilitation to patients in their homes. They have efficiently scaled their outreach and activation of in-home patients, and, importantly, they have a proven track record of utilizing existing reimbursement codes from both government and commercial health insurers. This presents an excellent opportunity to invest in a venture that has not only performed well financially but also makes a meaningful impact.","endorsement_name":"","investment_total":5000,"investment_info":"Invested $5,000 this round","is_lead_investor":true,"memo_paid_for_by_company":false,"related_urls":["https://wefunder.com/ryan.wheeler.1"]}],"investor_memos":[],"tab_counts":{"posts":5,"ask_questions":11,"featured_investors":2,"faq_entries":5},"active_fundraises":[{"id":120443,"entity_id":"wefunder:fundraise:120443","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"ttw","security_type":"","currency":"USD","testing_the_waters":true,"min_purchase":100,"max_purchase":9,"funding_target":1235000.0,"minimum_target":"50000.0","maximum_target":"1235000.0"},{"id":120442,"entity_id":"wefunder:fundraise:120442","state":"successful","offering_type":"4(a)(6)","funding_type":"note","structure":"equity","security_type":"equity","currency":"USD","testing_the_waters":false,"min_purchase":100,"max_purchase":9,"funding_target":50000.0,"minimum_target":"50000.0","maximum_target":"1235000.0","funding_started_at":"2024-09-21T00:28:31Z","funding_closed_at":"2025-08-01T03:59:59Z","auto_close_at":"2025-08-01T03:59:59Z"}],"latest_fundraise":{"id":120443,"entity_id":"wefunder:fundraise:120443","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null,"terms":{"eb":null,"nb":"$12M","txt":"pre-money valuation"}},"recent_posts":[{"id":273753,"entity_id":"wefunder:feed_item:273753","type":"FeedItem::Update","visibility":"public","title":"Imago Rehab Investor Update - February 2026","preview":"February was another breakout month at Imago. I wanted to share an update on new milestones as we continue to transform neuro-rehab care. This is a long read, but there’s a lot going on, and you deserve the details!📈Revenue GrowthWe continue to see strong revenue growth across all lines of business: Imago’s growth trajectory has been nothing short of remarkable since we acquired it last year, and at the end of February we were full booked in Virginia. Our immediate focus is scaling access by ...","published_at":"2026-03-10T22:21:15Z","author_name":"Sharon Samjitsingh","url":"/feed/273753","canonical_url":"https://wefunder.com/feed/273753"},{"id":260050,"entity_id":"wefunder:feed_item:260050","type":"FeedItem::Update","visibility":"public","title":"Imago Rehab Investor Update - January 2026","preview":"January was a strong start to the year for Imago, with record-breaking revenue momentum and growing visibility across the health innovation ecosystem. Here’s a quick update:💰Revenue Highlights Imago: January marked the highest number of visits per month ever! Revenue from stroke rehab via online advertising has nearly tripled since the majority acquisition by HCO, and set new records for weekly scheduled visits twice in January.🗃️Administrative Updates Final Imago documents have now been sign...","published_at":"2026-02-16T20:42:13Z","author_name":"Sharon Samjitsingh","url":"/feed/260050","canonical_url":"https://wefunder.com/feed/260050"},{"id":228456,"entity_id":"wefunder:feed_item:228456","type":"FeedItem::Update","visibility":"public","title":"Imago Rehab Investor Update – November 2025","preview":"Dear Investors,November has been a strong month across the board with continued momentum at HCO and a breakout month for Imago. Final documentation for the Imago acquisition is also in the final stages. 🔥 Imago Hits Major MilestonesNovember was Imago’s second-best month on record, with revenue above target for Month 1 post-acquisition. Board Continuity: Our board observers from Desert Angels and CyberVentures have committed to staying on through the next phase of growth. New National Channel ...","published_at":"2025-12-07T18:36:18Z","author_name":"Sharon Samjitsingh","url":"/feed/228456","canonical_url":"https://wefunder.com/feed/228456"},{"id":193503,"entity_id":"wefunder:feed_item:193503","type":"FeedItem::Update","visibility":"public","title":"⌛Last Chance to Invest in HCO: Community Round Closes Today","preview":"Hello everyone, this is Sharon, CEO at HCO.We're thrilled that Imago has found a home at HCO. As we've started integrating more with the team we're more determined than ever to accelerate Imago's mission, increase access to care, and restore dignity, independence to stroke survivors.We shared some more about our shared vision in our Closing Webinar for HCO's Community Round. You can find the replay here. If you have the time, I'm sure you'll see that we're all energized about this.Now, you ha...","published_at":"2025-09-28T16:02:17Z","author_name":"Sharon Samjitsingh","url":"/feed/193503","canonical_url":"https://wefunder.com/feed/193503"},{"id":185549,"entity_id":"wefunder:feed_item:185549","type":"FeedItem::Update","visibility":"public","title":"🚨Big News: HCO Acquires Majority Stake in Imago Rehab 🚨","preview":"Imago investors have already heard the news, and now we’re sharing it with our followers: Health Care Originals (HCO) has entered a definitive agreement to acquire a majority stake in Imago Rehab. HCO is a venture-backed leader in AI-powered personalized care for overlooked chronic conditions.This move secures an exciting future for Imago’s breakthrough stroke rehabilitation technology. Under HCO’s leadership, development of the Imago smart rehab glove will continue, backed by a team with dee...","published_at":"2025-09-09T19:24:45Z","author_name":"Sharon Samjitsingh","url":"/feed/185549","canonical_url":"https://wefunder.com/feed/185549"}],"q_and_a":[{"id":297620,"entity_id":"wefunder:comment:297620","question":"Hi team, I have a background in physical therapy and this is very interesting technology. I'd love to learn a bit more about your business model. How would you describe your go-to-market approach? How will Imago charge it's clinical partners and distributors of it's technology? What are the unit economics on these devices? Where can I read the primary research on your device, I couldn't find any literature on your website. Could you help me understand how you arrived at the $12M valuation? Based on revenue multiple, this seems a little high, but I expect there are more details under the surface. What do you expect your patents are worth? What have you received and what do you anticipate in terms of grants? What does your sales pipeline look like and what are you anticipating for revenue generation in 2025? Very interested to learn more about your awesome tech, thank you!","author_name":"Justin Olson","votes":1,"created_at":"2024-12-07T17:26:20Z","canonical_url":"https://wefunder.com/imago#question-297620","answers":[{"id":299409,"entity_id":"wefunder:comment:299409","answer":"Imago Rehab is an outpatient clinical practice, so we submit claims to Medicare part B and Commercial Insurance for OT, PT, and Speech Therapy. Imago Rehab is supporting Harvard on the development of advanced sensors and a shoulder soft wearable robotic device funded by the National Science Foundation grant. Our glove is published in a peer-reviewed journal, wearable technologies: URL link here: https://www.cambridge.org/core/journals/wearable-technologies/article/combining-soft-robotics-and-telerehabilitation-for-improving-motor-function-after-stroke/60A43ECC3F957B2C89A4CB6100E16D88 That is the glove in isolation, our novel clinical protocol is delivering 12.5 pts improvement on the Fugl Meyer assessment on average for our patient population, which is unprecedented in clinical literature and setting a new world record.","author_name":"Chris Dugan","votes":2,"created_at":"2025-01-03T18:36:58Z"}]},{"id":297422,"entity_id":"wefunder:comment:297422","question":"Hello Imago Team, I’m Zac Stahlhut with D3VC. We specialize in investment crowdfunding and are keenly interested in your innovative approach to rehabilitation. With your ambitious goals for rapid expansion and technology enhancements, I’d like to get a clearer picture of your strategy. Is your technology adaptable to other parts of the body, and how do you plan to manage distribution for unique cases? What progress are you making toward your 2024 revenue targets, and how has your partnership with AARP supported this growth? Finally, with your plans for scaling, do you anticipate any regulatory requirements, such as FDA approvals, impacting your path forward? Thank you for your time and insights!","author_name":"Zac Stahlhut","votes":1,"created_at":"2024-12-04T20:59:25Z","canonical_url":"https://wefunder.com/imago#question-297422","answers":[{"id":299407,"entity_id":"wefunder:comment:299407","answer":"Zac, thanks for these great questions. We have some partnerships that just deployed in 4Q24, and they are now activating with patient volumes in 1Q25 setting 2025 up for an exciting growth year. In addition to our glove, we are collaborating with Harvard on a shoulder device, the R\u0026amp;D is funded by the National Science Foundation grant. So Imago is an ecosystem platform leveraging AI and soft wearable robotic devices with a solutions roadmap to address patient needs in a clinically comprehensive way. This allows us to address the multiple clinical needs of stroke patients, but also allows us to support broader clinical conditions such as Multiple Sclerosis, Parkinsons, Traumatic Brain Injury, etc. Our devices will be 510k exempt FDA registered.","author_name":"Chris Dugan","votes":0,"created_at":"2025-01-03T18:29:36Z"}]},{"id":309520,"entity_id":"wefunder:comment:309520","question":"How long to you anticipate it will tatak to obtain licenses in an all 50 states?","author_name":"Alan And Leah Sakowitz","votes":0,"created_at":"2025-06-11T07:43:36Z","canonical_url":"https://wefunder.com/imago#question-309520","answers":[]},{"id":309484,"entity_id":"wefunder:comment:309484","question":"When do yuo expect this round to close? When do you expect to be in all 50 states?","author_name":"Alan And Leah Sakowitz","votes":0,"created_at":"2025-06-10T19:40:57Z","canonical_url":"https://wefunder.com/imago#question-309484","answers":[{"id":309536,"entity_id":"wefunder:comment:309536","answer":"We have some opportunities that we are evaluating that may affect continuing with the Reg CF offering and are putting that effort on hold as we evaluate our best path. As this evaluation completes, we will update the WeFunder community and other interested investors. As far as reaching all 50 states, we have a long term plan with each state being evaluated for the opportunity it presents based on volumes, insurance coverage or saturation, and state licensure/laws that affect the implementation of telehealth services. Currently we are opening new state about every 90 days, but we hope to accelerate that process with additional funding. Thanks for these questions. Please reach out if you have any additional comments.","author_name":"Kristin Nuckols","votes":0,"created_at":"2025-06-11T14:41:56Z"}]},{"id":307383,"entity_id":"wefunder:comment:307383","question":"Hi Chris, I am impressed with your therapies and team. How long will the round be open? I expect to have funds to invest within the next 6 weeks. Also, how much revenue was generated in the first 4 months of this year and are you still on track to generate $9.4 M this year? Thank you, Alan","author_name":"Alan And Leah Sakowitz","votes":0,"created_at":"2025-05-02T16:02:37Z","canonical_url":"https://wefunder.com/imago#question-307383","answers":[{"id":307770,"entity_id":"wefunder:comment:307770","answer":"Alan, thanks for your note and outreach via email. I addressed your questions via email outreach.","author_name":"Chris Dugan","votes":0,"created_at":"2025-05-08T15:57:47Z"}]},{"id":307380,"entity_id":"wefunder:comment:307380","question":"When is round ending? - Is there any bonus for VIP members?","author_name":"Y S","votes":0,"created_at":"2025-05-02T15:45:29Z","canonical_url":"https://wefunder.com/imago#question-307380","answers":[{"id":307771,"entity_id":"wefunder:comment:307771","answer":"There is still room and time to invest. You'll want to jump in asap as lots of investors are jumping in right now.","author_name":"Chris Dugan","votes":0,"created_at":"2025-05-08T16:00:00Z"}]},{"id":304493,"entity_id":"wefunder:comment:304493","question":"Are you guys a C corp?","author_name":"Sunrays LLC","votes":0,"created_at":"2025-03-22T09:00:42Z","canonical_url":"https://wefunder.com/imago#question-304493","answers":[{"id":305009,"entity_id":"wefunder:comment:305009","answer":"We are a Delaware C-corp","author_name":"Chris Dugan","votes":0,"created_at":"2025-03-31T12:39:14Z"}]},{"id":304472,"entity_id":"wefunder:comment:304472","question":"Hello how long does it take for us to receive our return on investment? Thank you","author_name":"Lamour Bluitt","votes":0,"created_at":"2025-03-21T19:38:28Z","canonical_url":"https://wefunder.com/imago#question-304472","answers":[{"id":305010,"entity_id":"wefunder:comment:305010","answer":"Many factors play into a business' liquidity event such as capital market conditions. Imago is very focused on creating shareholder value. Presently our priorities are growth and cash flow break even profitability. Imago will have M\u0026amp;A exit potential in 2028.","author_name":"Chris Dugan","votes":0,"created_at":"2025-03-31T12:44:08Z"}]},{"id":304357,"entity_id":"wefunder:comment:304357","question":"Hey Chris, Many questions, thanks in advance! Patents 1. Can you comment on what your patents cover exactly and if they are utility patents? 2. It appears you license them from Harvard and the company does not own them. Under what (if any) conditions could you lose access to this license OR lose exclusivity? Effectiveness 1. I have seen numerous claims the AI assisted robotic wearable glove is 5x more effective than traditional rehab. Can you provide any peer reviewed studies to support these claims? I have reviewed your previously provided citation ( cambridge.org/core/j…B2C89A4CB6100E16D88) however this only involved 10 patients which were NOT compared to traditional physical therapy. Any additional data you have for review would be helpful Business operations 1. From a big picture point of view it seems your company and solution is uniquely positioned for stroke/CNS/SCI conditions however your company markets cardiovascular rehab as well. Can you discuss this in more detail? I am not seeing how your business model (AI assisted robotic wearable tech) lends to cardiac rehab? 2. What percent of your business is neuro vs cardiac? What is the percent breakdown in your 2028 56M projection? 3. How do you plan on capturing share in cardiac rehab compared to other remote tele-rehab companies? What differentiates you in the cardiac rehab space? 4. Along the lines of cardiac rehab, how do you plan to enter the pulm/geriatrics/ortho rehab segments? I am assuming your AI assisted robotic wearable tech is your key differentiator but fail to see how it helps with these other indications. Do you have other differentiators to help penetrate these verticals? 5. Can you comment on how you are acquiring customers? Are you targetting consumers, physicians, health-care systems? Would love to hear your strategy on this front? 6. You have mentioned 34 hospital partners and a texas hospital partner. Are these all for stroke rehabs vs cardio vs other rehab indications? Do these partnerships essentially refer all eligible patients to you for rehab? Help me understand what the typical agreement entails? 7. Can you comment on expected annual volume from the above partnerships? 8. Can you comment on your pipeline for future partnerships and your approach to acquiring them? Tech 1. Can you discuss the improvements planned for the imago glove 2.0. 2. Cost of the glove and gross margin? 3. What other products are you developing beyond hand dexterity? I've seen shoulder mentioned, any others. Investments: 1. Is there a concurrent Reg D offering? What are these terms? As I said, many questions, thanks in advance! Regards, David","author_name":"David Schrift","votes":0,"created_at":"2025-03-19T18:07:03Z","canonical_url":"https://wefunder.com/imago#question-304357","answers":[{"id":305012,"entity_id":"wefunder:comment:305012","answer":"David, thank you for these questions. there's a lot here, and I'd be happy to hop on a 30min zoom with you to help further answer. Yes, our neuro rehab care model is broader than stroke and can support neuro conditions such as Traumatic Brain Injury, Multiple Sclerosis, and Parkinsons. Like any good product organization, we use voice-of-customer to inform solution design. Our first voice-of-customer is the patient, our second is the physician/hospital system provider partner. Listening to our voice-of-customer from the provider partners, they asked us if we could also support cardiac and pulmonary rehab. In these populations, it's not so much the glove medical device as applicable but rather our novel clinical protocols in how patients are able to experience rehab as personalized and customized to their home environment and how we leverage computer vision artificial intelligence as a clinical decision support of movement therapy for those populations. Furthermore, our technology platform is architected to incorporate data as a platform rather than a singular device. So Imago can integrate multiple devices (blood pressure cuffs, pulse oximeters, etc). Provider partners desire partners like Imago who are clinically more comprehensive than others in the market. Because we have an ability to serve a broader set of patient populations than some other competitors in the market that might only focus on cardiac rehab (they don't support neuro or pulmonary), we are hearing from provider partners that we are a more attractive partner for them. Yes we have paralleled Reg D with Reg CF and the terms are equivalent.","author_name":"Chris Dugan","votes":0,"created_at":"2025-03-31T13:02:48Z"}]},{"id":304297,"entity_id":"wefunder:comment:304297","question":"Looks like you are 'oversubscribed', which according to terms eliminates the understanding of the shares distributed per dollar invested. I'd need that spelled out in certain terms in order to invest. Here is the language used for valuation of investment, \"If the Offering is oversubscribed beyond the Target Offering Amount, the Company will sell Shares on a basis to be determined by the Company’s management. \"","author_name":"Kyle Theobald","votes":0,"created_at":"2025-03-18T17:49:56Z","canonical_url":"https://wefunder.com/imago#question-304297","answers":[{"id":304299,"entity_id":"wefunder:comment:304299","answer":"Kyle, thanks for your question, the platform establishes goals which we just recently achieved due to strong investor interest, but still allows for the opportunity to invest as the round still has additional room. We will reset the goal higher. This does not prohibit you from investing. you can still do so.","author_name":"Chris Dugan","votes":0,"created_at":"2025-03-18T18:11:49Z"}]},{"id":299744,"entity_id":"wefunder:comment:299744","question":"Hello Chris, thank you for your detailed response. Your partnerships and recent progress are impressive, and it’s clear Imago is addressing a critical market need. I wanted to follow up with a question regarding your patents—specifically, what aspects of the technology or applications they protect. My team is also keen to delve deeper into the technical applications and how they’re being scaled to broader clinical conditions. If you’re open to further discussion, please feel free to email me at zstahlhut@d3vc.ai to arrange a call. Looking forward to connecting further!","author_name":"Zac Stahlhut","votes":0,"created_at":"2025-01-09T00:14:17Z","canonical_url":"https://wefunder.com/imago#question-299744","answers":[{"id":299837,"entity_id":"wefunder:comment:299837","answer":"Followed up via email to schedule time to discuss, we are issuing a press release today or Monday on our third patent being granted. Will update WeFunder investors with that news once we have the PR out.","author_name":"Chris Dugan","votes":0,"created_at":"2025-01-10T15:44:39Z"}]}],"faq":[{"question":"Hello Imago Team, I’m Zac Stahlhut with D3VC. We specialize in investment crowdfunding and are keenly interested in your innovative approach to rehabilitation. With your ambitious goals for rapid expansion and technology enhancements, I’d like to get a clearer picture of your ...","answer":"Zac, thanks for these great questions. We have some partnerships that just deployed in 4Q24, and they are now activating with patient volumes in 1Q25 setting 2025 up for an exciting growth year. In addition to our glove, we are collaborating with Harvard on a shoulder device, the R\u0026amp;D is funded by the National Science Foundation grant. So Imago is an ecosystem platform leveraging AI and soft wearable robotic devices with a solutions roadmap to address patient needs in a clinically comprehe..."},{"question":"Hi team, I have a background in physical therapy and this is very interesting technology. I'd love to learn a bit more about your business model. How would you describe your go-to-market approach? How will Imago charge it's clinical partners and distributors of it's technology...","answer":"Imago Rehab is an outpatient clinical practice, so we submit claims to Medicare part B and Commercial Insurance for OT, PT, and Speech Therapy. Imago Rehab is supporting Harvard on the development of advanced sensors and a shoulder soft wearable robotic device funded by the National Science Foundation grant. Our glove is published in a peer-reviewed journal, wearable technologies: URL link here: https://www.cambridge.org/core/journals/wearable-technologies/article/combining-soft-robotics-and-..."},{"question":"Hello Chris, thank you for your detailed response. Your partnerships and recent progress are impressive, and it’s clear Imago is addressing a critical market need. I wanted to follow up with a question regarding your patents—specifically, what aspects of the technology or appl...","answer":"Followed up via email to schedule time to discuss, we are issuing a press release today or Monday on our third patent being granted. Will update WeFunder investors with that news once we have the PR out."},{"question":"Looks like you are 'oversubscribed', which according to terms eliminates the understanding of the shares distributed per dollar invested. I'd need that spelled out in certain terms in order to invest. Here is the language used for valuation of investment, \"If the Offering is o...","answer":"Kyle, thanks for your question, the platform establishes goals which we just recently achieved due to strong investor interest, but still allows for the opportunity to invest as the round still has additional room. We will reset the goal higher. This does not prohibit you from investing. you can still do so."},{"question":"Hey Chris, Many questions, thanks in advance! Patents 1. Can you comment on what your patents cover exactly and if they are utility patents? 2. It appears you license them from Harvard and the company does not own them. Under what (if any) conditions could you lose access to t...","answer":"David, thank you for these questions. there's a lot here, and I'd be happy to hop on a 30min zoom with you to help further answer. Yes, our neuro rehab care model is broader than stroke and can support neuro conditions such as Traumatic Brain Injury, Multiple Sclerosis, and Parkinsons. Like any good product organization, we use voice-of-customer to inform solution design. Our first voice-of-customer is the patient, our second is the physician/hospital system provider partner. Listening to our..."}]}}}